Hamilton Lanette R, George Dena L, Scoville Stephanie L, Hospenthal Duane R, Griffith Matthew E
Tripler Army Medical Center, MCHK-DP, Microbiology Rm 2H211, 1 Jarrett White Road, Honolulu, HI 96859-5000, USA.
Mil Med. 2011 Jan;176(1):103-5. doi: 10.7205/milmed-d-10-00111.
Acute Q fever is occasionally seen in U.S. military service members deployed to Iraq. Diagnosis relies on serology, which is not available in the combat zone. Improved diagnostic modalities are needed. We performed a pilot study investigating whether Joint Biological Agent Identification and Diagnostic System (JBAIDS), a ruggedized, deployable polymerase chain reaction (PCR) platform, might be useful in the diagnosis of acute Q fever. Patients presenting to a Combat Support Hospital in Iraq with undifferentiated fever had blood drawn for Q fever PCR and these results were compared with serology. PCR was positive in 6 of 9 patients with acute Q fever by serology and negative in all 9 patients with negative serology. These results suggest that PCR using the JBAIDS platform could be of use in the diagnosis of Q fever in deployed settings. Further research into this modality is warranted.
急性Q热偶尔会在美国部署到伊拉克的军人中出现。诊断依赖于血清学检测,但在作战区域无法进行此项检测。因此需要改进诊断方法。我们进行了一项初步研究,调查联合生物制剂识别与诊断系统(JBAIDS),一种坚固耐用、可部署的聚合酶链反应(PCR)平台,是否可用于急性Q热的诊断。在伊拉克一家战斗支援医院就诊的不明原因发热患者接受了Q热PCR检测,并将这些结果与血清学检测结果进行比较。在9例血清学确诊为急性Q热的患者中,6例PCR检测呈阳性,而9例血清学检测为阴性的患者PCR检测均为阴性。这些结果表明,使用JBAIDS平台的PCR检测可用于部署环境中Q热的诊断。有必要对这种检测方法进行进一步研究。